Illumina(ILMN)今日盘中大涨5.28%，引发市场广泛关注。
消息面上，公司即将于盘后发布第二财季业绩报告，市场对此抱有积极预期。此前，公司已连续两个季度业绩超预期：第一财季调整后每股收益1.15美元，超市场预期9.5%，营收10.90亿美元同比增长4.8%；全年营收指引为45.2亿至46.2亿美元，高于市场预期。此外，摩根大通近期将公司评级上调至"增持"，目标价上调至185美元；公司年内推出StrataMap空间解决方案、TruPath Genome全基因组工作流等多款新品，并获批15亿美元回购授权，业务动能持续增强，进一步提振了投资者信心。
在强劲基本面和多重利好因素的推动下，资金在财报披露前积极布局，带动股价盘中强势拉升。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.